BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19827120)

  • 1. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.
    Datema FR; Ferrier MB; van der Schroeff MP; Baatenburg de Jong RJ
    Head Neck; 2010 Jun; 32(6):728-36. PubMed ID: 19827120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
    Castro MA; Dedivitis RA; Ribeiro KC
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of severe malnutrition on short-term mortality and overall survival in head and neck cancer.
    Datema FR; Ferrier MB; Baatenburg de Jong RJ
    Oral Oncol; 2011 Sep; 47(9):910-4. PubMed ID: 21802345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel head and neck cancer survival analysis approach: random survival forests versus Cox proportional hazards regression.
    Datema FR; Moya A; Krause P; Bäck T; Willmes L; Langeveld T; Baatenburg de Jong RJ; Blom HM
    Head Neck; 2012 Jan; 34(1):50-8. PubMed ID: 21322080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
    Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
    Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity as a major risk factor for mortality and complications in head and neck surgery.
    Ferrier MB; Spuesens EB; Le Cessie S; Baatenburg de Jong RJ
    Arch Otolaryngol Head Neck Surg; 2005 Jan; 131(1):27-32. PubMed ID: 15655181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of survival in patients with head and neck cancer.
    Baatenburg de Jong RJ; Hermans J; Molenaar J; Briaire JJ; le Cessie S
    Head Neck; 2001 Sep; 23(9):718-24. PubMed ID: 11505480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
    Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of comorbidity on the prognosis of squamous cell carcinoma in the head and neck].
    Stein M; Herberhold C; Walther EK; Langenberg S
    Laryngorhinootologie; 2000 Jun; 79(6):345-9. PubMed ID: 10923315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for predicting transfusion requirements in head and neck surgery.
    Weber RS
    Laryngoscope; 1995 Aug; 105(8 Pt 2 Suppl 73):1-17. PubMed ID: 7630307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential prognostic impact of comorbidity in head and neck cancer.
    Alho OP; Hannula K; Luokkala A; Teppo H; Koivunen P; Kantola S
    Head Neck; 2007 Oct; 29(10):913-8. PubMed ID: 17510970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province.
    Tiwana MS; Wu J; Hay J; Wong F; Cheung W; Olson RA
    Oral Oncol; 2014 Jul; 50(7):651-6. PubMed ID: 24731736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
    Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
    Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans.
    Busquets JM; García HA; Trinidad-Pinedo J; Baez A
    P R Health Sci J; 2003 Sep; 22(3):259-64. PubMed ID: 14619452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.
    Nguyen TV; Yueh B
    Cancer; 2002 Aug; 95(3):553-62. PubMed ID: 12209747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival.
    Reyes-Gibby CC; Anderson KO; Merriman KW; Todd KH; Shete SS; Hanna EY
    J Pain; 2014 Oct; 15(10):1015-22. PubMed ID: 25043982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.